2010•Huaxi yaoxue zazhiRequires access

Preparation and in vitro release of CA4-loaded solid lipid nanoparticles

HE Ying-ju

Open publisher page 0 citations

Abstract

OBJECTIVE To prepare the CA4-loaded solid lipid nanoparticles(CA4-SLNs) and investigate its physicochemical properties and in vitro release profile.METHODS CA4-SLNs were prepared by the method of emulsification evaporation-solidification at low temperature.The morphology was examined by transmission electron microscope.The particle size and ξ potential were determined by laser granularity equipment.The unencapsulated CA4 and solid lipid nanoparticles were separated by centrifugation and the encapsulation efficiency and drug-loading efficiency were detected by HPLC.The in vitro release profile of CA4-SLNs was studied using dialysis technology.RESULTS The obtained SLNs were spherical.The mean particle size was 73.23 nm.The PDI was 0.238,and the ξ potential was-30.5 mV.The average encapsulation efficiency and drug loading of the optimized SLN were 98.62% and 3.89%.The release in vitro accorded to the Weibull order model:lnln[1 /(1-Q)]= 0.6123lnt-0.736(r = 0.9917).CONCLUSION The method of emulsification-evaporation was appropriate for the preparation of CA4-loaded solid lipid nanoparticles and the drug encapsulation efficiency was high.The in vitro release test showed that the drug could sustained-release from SLN after a burst release in initial phase.

About this research paper

What this paper is about

OBJECTIVE To prepare the CA4-loaded solid lipid nanoparticles(CA4-SLNs) and investigate its physicochemical properties and in vitro release profile.METHODS CA4-SLNs were prepared by the method of emulsification evaporation-solidification at low temperature.The morphology was examined by transmission electron microscope.The particle size and ξ potential were determined by laser granularity equipment.The unencapsulated CA4 and solid lipid nanoparticles were separated by centrifugation and the encapsulation efficiency and drug-loading efficiency were detected by HPLC.The in vitro release profile of CA4-SLNs was studied using dialysis technology.RESULTS The obtained SLNs were spherical.The mean particle size was 73.23 nm.The PDI was 0.238,and the ξ potential was-30.5 mV.The average encapsulation efficiency and drug loading of the optimized SLN were 98.62% and 3.89%.The release in vitro accorded to the Weibull order model:lnln[1 /(1-Q)]= 0.6123lnt-0.736(r = 0.9917).CONCLUSION The method of emulsification-evaporation was appropriate for the preparation of CA4-loaded solid lipid nanoparticles and the drug encapsulation efficiency was high.The in vitro release test showed that the drug could sustained-release from SLN after a burst release in initial phase.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To prepare the CA4-loaded solid lipid nanoparticles(CA4-SLNs) and investigate its physicochemical properties and in vitro release profile.METHODS CA4-SLNs were prepared by the method of emulsification evaporation-solidification at low temperature.The morphology was examined by transmission electron microscope.The particle size and ξ potential were determined by laser granularity equipment.The unencapsulated CA4 and solid lipid nanoparticles were separated by centrifugation and the encapsulation efficiency and drug-loading efficiency were detected by HPLC.The in vitro release profile of CA4-SLNs was studied using dialysis technology.RESULTS The obtained SLNs were spherical.The mean particle size was 73.23 nm.The PDI was 0.238,and the ξ potential was-30.5 mV.The average encapsulation efficiency and drug loading of the optimized SLN were 98.62% and 3.89%.The release in vitro accorded to the Weibull order model:lnln[1 /(1-Q)]= 0.6123lnt-0.736(r = 0.9917).CONCLUSION The method of emulsification-evaporation was appropriate for the preparation of CA4-loaded solid lipid nanoparticles and the drug encapsulation efficiency was high.The in vitro release test showed that the drug could sustained-release from SLN after a burst release in initial phase.

Key concepts: Solid lipid nanoparticle, Chemistry, Particle size, Nanoparticle, Chromatography, Chemical engineering, Nanotechnology, Materials science

Related papers

Back to paper searchBrowse research topicsOriginal source
Preparation and in vitro release of CA4-loaded solid lipid nanoparticles — Research Paper | ScholarLens